Merck
  • Home
  • Search Results
  • Mitochondrial impairment and oxidative stress in leukocytes after testosterone administration to female-to-male transsexuals.

Mitochondrial impairment and oxidative stress in leukocytes after testosterone administration to female-to-male transsexuals.

The journal of sexual medicine (2013-11-21)
Víctor M Victor, Milagros Rocha, Celia Bañuls, Susana Rovira-Llopis, Marcelino Gómez, Antonio Hernández-Mijares
ABSTRACT

Testosterone undecanoate (T) treatment is common in female-to-male transsexuals (FtMs) but can induce impairment of mitochondrial function and oxidative stress. The effect of T treatment on the mitochondrial function and redox state of leukocytes of FtMs subjects was evaluated. This was an observational study conducted in a university hospital. Fifty-seven FtMs were treated with T (1,000 mg) for 12 weeks, after which anthropometric and metabolic parameters and mitochondrial function were evaluated. Anthropometric and metabolic parameters were evaluated. Mitochondrial function was studied by assessing mitochondrial oxygen (O2) consumption, membrane potential, reactive oxygen species (ROS) production, glutathione levels (GSH), and the reduced glutathione/oxidized glutathione (GSH)/(GSSG) ratio in polymorphonuclear cells. T treatment led to mitochondrial impairment in FtMs as a result of a decrease in mitochondria O2 consumption, the membrane potential, GSH levels, and the (GSH)/(GSSG) ratio and an increase in ROS production. Mitochondrial O2 consumption and membrane potential negatively correlated with T levels, which was further confirmed that the T treatment had induced mitochondrial dysfunction. T also produced a significant increase in total testosterone, free androgenic index, and atherogenic index of plasma, and a decrease in sex hormone-binding globulin and high-density lipoprotein cholesterol. Treatment of FtMs with T can induce impairment of mitochondrial function and a state of oxidative stress. This effect should be taken into account in order to modulate possible comorbidities in these patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
トリパンブルー 溶液, 0.4%, liquid, sterile-filtered, suitable for cell culture
Millipore
過酸化水素 溶液, 3%, suitable for microbiology
Sigma-Aldrich
HEPES緩衝液, 1 M in H2O
SAFC
HEPES
Sigma-Aldrich
トリパンブルー 溶液, 0.4%, for microscopy
Sigma-Aldrich
過酸化水素 溶液, 34.5-36.5%
Sigma-Aldrich
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
トリパンブルー, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
過酸化水素 溶液, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
過酸化水素 溶液, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
SAFC
HEPES
Sigma-Aldrich
トリパンブルー, Dye content 60 %
Sigma-Aldrich
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
Sigma-Aldrich
過酸化水素 溶液, JIS special grade, 30.0-35.5%
Sigma-Aldrich
過酸化水素 溶液, SAJ first grade, ≥30.0%
Sigma-Aldrich
HEPES, anhydrous, free-flowing, Redi-Dri, ≥99.5%
Supelco
HEPES, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
HEPES, ≥99.0%